11 – 20 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
(
- Contribution to journal › Article
-
Mark
An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
(
- Contribution to journal › Article
-
Mark
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
(
- Contribution to journal › Scientific review
-
Mark
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions
(
- Contribution to journal › Article
- 2020
-
Mark
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
(
- Contribution to journal › Article
-
Mark
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18(
- Contribution to journal › Published meeting abstract
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
(
- Contribution to journal › Scientific review
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival
(
- Contribution to journal › Published meeting abstract